Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
Recruitment status was: Active, not recruiting
I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
|Study Design:||Primary Purpose: Treatment|
|Study Start Date:||May 1990|
PROTOCOL OUTLINE: Patients receive colchicine orally twice daily for 24 months. After the first month, the dose of colchicine will increase and remain at that dose for the duration of study.
Patients are evaluated every 6 months during study.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004368
|Study Chair:||Ronald J. Sokol||Children's Hospital Colorado|